Clinical Trials Browser

Interventional × Recurrent Uterine Corpus Carcinoma × Clear all

NCT00063999 2021-10-19

Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer

Phase 3 Completed

1,381 enrolled 12 charts

Recurrent Uterine Corpus Carcinoma

NCT00027690 2019-07-23

Gefitinib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Phase 2 Completed

Recurrent Uterine Corpus Carcinoma

NCT00006903 2019-03-20

Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer

Phase 2 Unknown

67 enrolled 9 charts

Recurrent Uterine Corpus Carcinoma